Dr Sulaiman Al Habib Medical Services (4013) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue rose to SAR 3,436 million, up 8.8% year-over-year, with growth in hospitals, pharmacies, and solutions.

• Net income declined 9.6% year-over-year to SAR 503.3 million, with net income margin dropping to 14.65%.

• Gross profit margin decreased to 27.82% from 32.56% in Q1 2025.

• Robust expansion with several new hospitals opened in 2024–2025 and multiple projects underway for 2027–2029.

• Group operates hospitals, pharmacies, and healthcare-related services in Saudi Arabia and UAE.

Financial highlights

• Revenue increased to SAR 3,436 million (+8.8% year-over-year).

• Gross profit fell to SAR 955.97 million, with margin down 4.74 percentage points.

• EBITDA rose to SAR 854 million (+4.7%), but EBITDA margin declined to 24.84%.

• Net income dropped to SAR 503.3 million, with EPS at SAR 1.44.

• Total assets increased to SAR 23,766.3 million from SAR 23,204.9 million at year-end 2025.

Outlook and guidance

• Ongoing expansion with new hospitals and medical centers planned through 2029.

• Continued investment in technology, digital health, and ESG initiatives.

• Management continues to monitor regional geopolitical developments, with no material impact on Q1 2026 results.